Peter Caravan
Clinical trials sponsored by Peter Caravan, explained in plain language.
-
New imaging study reveals how immune drugs impact lung scarring
Knowledge-focused Recruiting nowThis study looks at how immunosuppression treatment changes lung scarring in people with certain types of interstitial lung disease (not IPF). Using advanced PET and MRI scans, researchers will measure collagen buildup and tissue damage. The goal is to better understand the effec…
Phase: PHASE2 • Sponsor: Peter Caravan • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New scans may predict lung scarring speed
Knowledge-focused Recruiting nowThis study tests whether special PET and MRI scans can predict how fast lung scarring (pulmonary fibrosis) will get worse in 60 adults aged 18-80 with certain types of this disease. Participants will have scans and breathing tests over 2 years. The goal is to see if these imaging…
Phase: PHASE2 • Sponsor: Peter Caravan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC